Virginia HB 2233: Prescription drug price transparency; manufacturer reporting requirements.

Status: Left in Commerce and Energy (as of 2023-02-07)

State: Virginia · Session: 2023 · Bill: HB 2233

Sponsors: Sickles

View Virginia HB 2233 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.